241 related articles for article (PubMed ID: 9712018)
1. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity.
van de Wal Y; Kooy Y; van Veelen P; Peña S; Mearin L; Papadopoulos G; Koning F
J Immunol; 1998 Aug; 161(4):1585-8. PubMed ID: 9712018
[TBL] [Abstract][Full Text] [Related]
2. T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase.
Molberg O; McAdam S; Lundin KE; Kristiansen C; Arentz-Hansen H; Kett K; Sollid LM
Eur J Immunol; 2001 May; 31(5):1317-23. PubMed ID: 11465088
[TBL] [Abstract][Full Text] [Related]
3. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.
Dørum S; Qiao SW; Sollid LM; Fleckenstein B
J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248
[TBL] [Abstract][Full Text] [Related]
4. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase.
Arentz-Hansen H; Körner R; Molberg O; Quarsten H; Vader W; Kooy YM; Lundin KE; Koning F; Roepstorff P; Sollid LM; McAdam SN
J Exp Med; 2000 Feb; 191(4):603-12. PubMed ID: 10684852
[TBL] [Abstract][Full Text] [Related]
5. Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease.
Dieterich W; Esslinger B; Trapp D; Hahn E; Huff T; Seilmeier W; Wieser H; Schuppan D
Gut; 2006 Apr; 55(4):478-84. PubMed ID: 16188922
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of in vitro deamidation of gliadin peptic fragment by mass spectrometry may reflect one of the molecular mechanisms taking place in celiac disease development.
Novák P; Man P; Tucková L; Tlaskalová-Hogenová H; Bezouska K; Havlícek V
J Mass Spectrom; 2002 May; 37(5):507-11. PubMed ID: 12112756
[TBL] [Abstract][Full Text] [Related]
7. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope.
Anderson RP; Degano P; Godkin AJ; Jewell DP; Hill AV
Nat Med; 2000 Mar; 6(3):337-42. PubMed ID: 10700238
[TBL] [Abstract][Full Text] [Related]
8. Tissue transglutaminase--the key player in celiac disease: a review.
Reif S; Lerner A
Autoimmun Rev; 2004 Jan; 3(1):40-5. PubMed ID: 14871648
[TBL] [Abstract][Full Text] [Related]
9. Evidence of a selective epitope loss of anti-transglutaminase immunoreactivity in gluten-free diet celiac sera: a new tool to distinguish disease-specific immunoreactivities.
Tiberti C; Bonamico M; Dotta F; Verrienti A; Di Tola M; Liu E; Ferri M; Nenna R; Picarelli A; Eisenbarth GS
Clin Immunol; 2006 Oct; 121(1):40-6. PubMed ID: 16798097
[TBL] [Abstract][Full Text] [Related]
10. Blocking peptides decrease tissue transglutaminase processing of gliadin in vitro.
Hoffmann K; Alminger M; Andlid T; Chen T; Olsson O; Sandberg AS
J Agric Food Chem; 2009 Nov; 57(21):10150-5. PubMed ID: 19813732
[TBL] [Abstract][Full Text] [Related]
11. Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease.
Gianfrani C; Siciliano RA; Facchiano AM; Camarca A; Mazzeo MF; Costantini S; Salvati VM; Maurano F; Mazzarella G; Iaquinto G; Bergamo P; Rossi M
Gastroenterology; 2007 Sep; 133(3):780-9. PubMed ID: 17678925
[TBL] [Abstract][Full Text] [Related]
12. Unexpected role of surface transglutaminase type II in celiac disease.
Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M
Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941
[TBL] [Abstract][Full Text] [Related]
13. Immunogenic peptides can be detected in whole gluten by transamidating highly susceptible glutamine residues: implication in the search for gluten-free cereals.
Mamone G; Camarca A; Fierro O; Sidney J; Mazzarella G; Addeo F; Auricchio S; Troncone R; Sette A; Gianfrani C
J Agric Food Chem; 2013 Jan; 61(3):747-54. PubMed ID: 23244345
[TBL] [Abstract][Full Text] [Related]
14. Antagonist peptides of the gliadin T-cell stimulatory sequences: a therapeutic strategy for celiac disease.
Silano M; Vincentini O; Iapello A; Mancini E; De Vincenzi M
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S191-2. PubMed ID: 18685513
[TBL] [Abstract][Full Text] [Related]
15. Deamidation and cross-linking of gliadin peptides by transglutaminases and the relation to celiac disease.
Skovbjerg H; Koch C; Anthonsen D; Sjöström H
Biochim Biophys Acta; 2004 Nov; 1690(3):220-30. PubMed ID: 15511629
[TBL] [Abstract][Full Text] [Related]
16. Natural variation in toxicity of wheat: potential for selection of nontoxic varieties for celiac disease patients.
Spaenij-Dekking L; Kooy-Winkelaar Y; van Veelen P; Drijfhout JW; Jonker H; van Soest L; Smulders MJ; Bosch D; Gilissen LJ; Koning F
Gastroenterology; 2005 Sep; 129(3):797-806. PubMed ID: 16143119
[TBL] [Abstract][Full Text] [Related]
17. Expression and enzymatic activity of small intestinal tissue transglutaminase in celiac disease.
Esposito C; Paparo F; Caputo I; Porta R; Salvati VM; Mazzarella G; Auricchio S; Troncone R
Am J Gastroenterol; 2003 Aug; 98(8):1813-20. PubMed ID: 12907337
[TBL] [Abstract][Full Text] [Related]
18. Antigen presentation to celiac lesion-derived T cells of a 33-mer gliadin peptide naturally formed by gastrointestinal digestion.
Qiao SW; Bergseng E; Molberg Ø; Xia J; Fleckenstein B; Khosla C; Sollid LM
J Immunol; 2004 Aug; 173(3):1757-62. PubMed ID: 15265905
[TBL] [Abstract][Full Text] [Related]
19. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells.
de Kauwe AL; Chen Z; Anderson RP; Keech CL; Price JD; Wijburg O; Jackson DC; Ladhams J; Allison J; McCluskey J
J Immunol; 2009 Jun; 182(12):7440-50. PubMed ID: 19494267
[TBL] [Abstract][Full Text] [Related]
20. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease.
Molberg O; Mcadam SN; Körner R; Quarsten H; Kristiansen C; Madsen L; Fugger L; Scott H; Norén O; Roepstorff P; Lundin KE; Sjöström H; Sollid LM
Nat Med; 1998 Jun; 4(6):713-7. PubMed ID: 9623982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
